Home | Business News | Browse by Publication | M | M2 Presswire

OTCPicks.com Stocks to Watch for Monday, April 30th MLPH, WNSH, ZPNW, RRGI, TNOG, TCCO.

Article Excerpt
M2 PRESSWIRE-30 April 2007-OTCPicks.com: OTCPicks.com Stocks to Watch for Monday, April 30th MLPH, WNSH, ZPNW, RRGI, TNOG, TCCO(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:30042007

Our Stocks to Watch for tomorrow include Molecular Pharmacology(OTCBB: MLPH), Winsted Holdings Inc(OTC: WNSH), Zippi Networks(OTC: ZPNW), Reality Racing (OTC: RRGI), Titan Oil and Gas(OTC: TNOG), Technical Communications Corp(OTCBB: TCCO)

Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts

MOLECULAR PHARMACOLOGY (OTCBB: MLPH) "Up 108% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/MLPH.php

Molecular Pharmacology (USA) Limited is a public biotechnology company dedicated to the discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL compound. MPL USA holds the exclusive worldwide rights to develop new and fast-acting analgesic and anti-inflammatory products based on MPL-TL. For more information on MPL USA, please visit www.mpl-usa.com

MLPH News:

April 25 - Progress in Molecular's Drug Discovery Program to Be Presented at the World Congress on Inflammation

Molecular Pharmacology (USA) Limited (OTCBB: MLPH) (the "Company") recently announced that its progress in its drug discovery program collectively operated by its Australian subsidiary Molecular Pharmacology Limited and its principal shareholder, Pharmanet Group Limited ("MPL Group"), will be presented at the 8th World Congress on Inflammation in Copenhagen in June 2007.

The MPL Group has received invitations from the Scientific Committee of the World Congress to present three separate scientific papers on developments of the Company's licensed topical anti-cytokine and anti-inflammatory drug developments.

The World Congress on Inflammation is one of the premier scientific forums for new discoveries in inflammation control and management. Management believes to have three papers accepted at such a prestigious forum provides a strong endorsement of the scientific quality of the Company's drug discovery program.

The three papers to be presented in Copenhagen in June 2007 cover the management of sun-damage and photo-aging using MPL Group's topical anti-cytokine complex, the reduction of pro-inflammatory cytokines in human monocytes using MPL Groups Zn-plasma protein complex and the influence of MPL Group's patented trace element complex on managing pro-inflammatorily cytokines in arthritis.

The three papers to be presented at the World Congress on Inflammation represent only a small part of MPL Group's recent progress in the development of its proprietary Tripeptofen drug development platform. The public release of this new data in Copenhagen has only recently been made possibly by completion of the Company's expanded intellectual property program.

WINSTED HOLDINGS INC (OTC: WNSH) "Up 100% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/WNSH.php

Winsted Holdings Inc. (OTCBB: WNSH) is a Business Development Company (BDC) located in Newport Beach, California. BDCs are publicly traded, closed-end investment companies regulated by the Investment Company Act of 1940. The Company was founded on the premise that combining both operational talent and financial talent within a single private equity investment firm can significantly enhance the magnitude and consistency of investment returns. Winsted Holdings' team consists of accomplished financial professionals with experience at prestigious financial institutions, seasoned corporate executives from various industry enterprises and successful entrepreneurs with expertise developed in aspects from business development to capital markets and from sales and marketing to technology development. The Company currently has two wholly owned subsidiaries, Spencer Communications Inc. and MedSpa Solutions Inc. Over the coming months, the Company...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!